Patents by Inventor Jeffrey A. Schuster

Jeffrey A. Schuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11977086
    Abstract: Methods, systems and techniques for the accurate measurement breath-borne biomarkers are disclosed. Such methods, systems and techniques may be used for the purposes of detection and/or measurement in breath samples of biomarkers.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: May 7, 2024
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster, Jeffrey A. Stoll
  • Patent number: 11890090
    Abstract: An example breath collection and sampling device disclosed herein comprises a cartridge housing having a breath capture module, and a rotary valve operatively coupling a mouthpiece with the breath capture module. The rotary valve can have an open position where breath of a user can pass through the rotary valve, across capture sites of the breath capture module, and into a vacuum port, and a closed position for sealing the breath capture module from fluid passing through the rotary valve, while allowing the breath capture module to be exposed to a reagent for subsequent analysis of contents within the captured breath.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: February 6, 2024
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Kevin M. Limtao, Jeffrey A. Schuster, Peter A. Holst
  • Patent number: 11821821
    Abstract: Methods, systems and techniques for the accurate measurement of breath-borne biomarkers are disclosed. Such methods, systems and techniques may be used for the purposes of detection and/or measurement in breath samples of biomarkers, e.g., biomarkers relating to a disease or a physiological condition.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: November 21, 2023
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster, Jeffrey A. Stoll
  • Publication number: 20230309857
    Abstract: A system comprises a mouth piece to receive exhaled air; a breath chamber to receive exhaled air; a valve to direct exhaled air along a desired flow path, direct purge gas along a desired flow path, control the rate of flow of purge gas, control the rate of flow of exhaled air, block the flow of purge gas, and/or block the flow of exhaled air; a source of purge gas; a CO2 cartridge to remove CO2; a water cartridge to remove water; a breath cartridge to capture VOCs from exhaled air; a temperature control system to control the temperature of CO2 cartridge, a water cartridge, and/or a breath cartridge; a cryostat to contain and limit heat flow to a cryogenic liquid; a flow meter designed to measure the flow of exhaled air and/or purge gas; and a pressure transducer to measure a pressure, a flow rate, and/or a flow volume.
    Type: Application
    Filed: April 13, 2023
    Publication date: October 5, 2023
    Inventors: Chris Wheeler, Chris Todd, Jeffrey A. Schuster, Karl-Magnus Larsson
  • Patent number: 11747353
    Abstract: Systems and techniques for collecting and analyzing breath samples to detect one or more target analytes are disclosed.
    Type: Grant
    Filed: November 16, 2021
    Date of Patent: September 5, 2023
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster
  • Patent number: 11660021
    Abstract: A system comprises a mouth piece to receive exhaled air; a breath chamber to receive exhaled air; a valve to direct exhaled air along a desired flow path, direct purge gas along a desired flow path, control the rate of flow of purge gas, control the rate of flow of exhaled air, block the flow of purge gas, and/or block the flow of exhaled air; a source of purge gas; a CO2 cartridge to remove CO2; a water cartridge to remove water; a breath cartridge to capture VOCs from exhaled air; a temperature control system to control the temperature of CO2 cartridge, a water cartridge, and/or a breath cartridge; a cryostat to contain and limit heat flow to a cryogenic liquid; a flow meter designed to measure the flow of exhaled air and/or purge gas; and a pressure transducer to measure a pressure, a flow rate, and/or a flow volume.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 30, 2023
    Assignee: Diagnose Early, Inc.
    Inventors: Chris Wheeler, Chris Todd, Jeffrey A. Schuster, Karl-Magnus Larsson
  • Publication number: 20230115432
    Abstract: The present disclosure provides methods and devices for early diagnosis of an infection, for example by the COVID-19 virus, and determining a course of action for treatment of the infection.
    Type: Application
    Filed: March 26, 2021
    Publication date: April 13, 2023
    Inventors: Chris Wheeler, Karl-Magnus Larsson, Jeffrey A. Schuster
  • Patent number: 11426097
    Abstract: An example breath collection and sampling device disclosed herein comprises a cartridge housing having a breath capture module, and a rotary valve operatively coupling a mouthpiece with the breath capture module. The rotary valve can have an open position where breath of a user can pass through the rotary valve, across capture sites of the breath capture module, and into a vacuum port, and a closed position for sealing the breath capture module from fluid passing through the rotary valve, while allowing the breath capture module to be exposed to a reagent for subsequent analysis of contents within the captured breath.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: August 30, 2022
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Kevin M. Limtao, Jeffrey A. Schuster, Peter A. Holst
  • Patent number: 11187711
    Abstract: Systems and techniques for collecting and analyzing breath samples to detect one or more target analytes are disclosed.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: November 30, 2021
    Assignee: Hound Labs, Inc.
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster
  • Publication number: 20200300876
    Abstract: Methods, systems and techniques for the accurate measurement breath-borne biomarkers are disclosed. Such methods, systems and techniques may be used for the purposes of detection and/or measurement in breath samples of biomarkers.
    Type: Application
    Filed: March 18, 2020
    Publication date: September 24, 2020
    Inventors: Michael Scott Lynn, Joseph A. Heanue, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster, Jeffrey A. Stoll
  • Publication number: 20200245899
    Abstract: The present disclosure describes systems, methods, and apparatus for a portable and handheld mechanical breath collection device. The mechanical breath collection device collects air from a human subject, filters out saliva from the human subject, and collects aerosolized droplets from the received air via inertial impaction on an impactor surface. A target chemical is then extracted from the collected aerosolized droplets, and analyzed. In this way, a concentration of a target chemical present from the human subject can be determined by the portable and handheld device.
    Type: Application
    Filed: May 29, 2019
    Publication date: August 6, 2020
    Inventors: Joseph A. Heanue, Jeffrey A. Stoll, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster
  • Publication number: 20200245898
    Abstract: The present disclosure describes a single-use microfluidic cartridge that is can be utilized with a portable and handheld breath collection and analysis device to detect a presence of a target chemical in human breath. The cartridge receives an air sample of human breath, processes it to extract the target chemical in solution, and reacts the solution with chemical reagent(s) to determine a concentration level of the target chemical present in the collected breath sample. Additionally, a portion of the collected sample can be contained in a separate reservoir of the cartridge of evidence preservation. The cartridge may further contain a cryptographic computing chip to store information regarding the sample processed within the cartridge.
    Type: Application
    Filed: May 29, 2019
    Publication date: August 6, 2020
    Inventors: Joseph A. Heanue, Jeffrey A. Stoll, Samartha G. Anekal, Kevin M. Limtao, Kevin Bradford Dunk, Jeffrey A. Schuster
  • Publication number: 20200187828
    Abstract: A system comprises a mouth piece to receive exhaled air; a breath chamber to receive exhaled air; a valve to direct exhaled air along a desired flow path, direct purge gas along a desired flow path, control the rate of flow of purge gas, control the rate of flow of exhaled air, block the flow of purge gas, and/or block the flow of exhaled air; a source of purge gas; a CO2 cartridge to remove CO2; a water cartridge to remove water; a breath cartridge to capture VOCs from exhaled air; a temperature control system to control the temperature of CO2 cartridge, a water cartridge, and/or a breath cartridge; a cryostat to contain and limit heat flow to a cryogenic liquid; a flow meter designed to measure the flow of exhaled air and/or purge gas; and a pressure transducer to measure a pressure, a flow rate, and/or a flow volume.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Inventors: Chris WHEELER, Chris TODD, Jeffrey A. SCHUSTER, Karl-Magnus LARSSON
  • Patent number: 9662449
    Abstract: A needle free injector system and a method for delivering a formulation using this system are disclosed. The method comprises actuating a needle free injector to pressurize a liquid formulation and force the formulation through an orifice in a skin puncture phase followed by injection of the formulation during a delivery phase. The skin puncture phase is defined by a pressure profile vs. time curve after actuation which has a main pressure peak with a maximum pressure. The delivery phase occurs at a lower pressure than the maximum pressure of the main peak pressure. The device may have one or more orifices and pressurizing the formulation during the puncture phase and delivery phase to extrude the formulation through each orifice is structured so as to improve characteristics of needle free delivery.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: May 30, 2017
    Assignee: Zogenix, Inc.
    Inventors: Brooks M. Boyd, Jeffrey A. Schuster
  • Publication number: 20160166766
    Abstract: A drug delivery monitoring system comprising a monitor is disclosed that utilizes sound to monitor the occurrence and properties of a drug delivery event. The monitor is affixed to the exterior of a drug delivery device or drug container, and thus does not require disassembly of the drug delivery device and cannot interfere with the operation of the drug delivery device. The monitoring system includes a display device such as a smart phone or tablet computer for analyzing data related to the drug delivery device usage and displaying information to a patient or caregiver before, during, and after a drug delivery event.
    Type: Application
    Filed: July 11, 2014
    Publication date: June 16, 2016
    Applicant: OSCILLARI LLC
    Inventors: Jeffrey A. SCHUSTER, Stephen J. FARR
  • Publication number: 20160151571
    Abstract: Systems and methods are described for treating un-met medical needs in migraine and related conditions such as cluster headache. Included are treatments that are both rapid onset and long acting, which include sustained release formulations, and combination products. Also included are treatments for multiple symptoms of migraine, especially headache and nausea and vomiting. Systems that are self contained, portable, prefilled, and simple to self administer at the onset of a migraine attack are disclosed, and preferably include a needle-free injector and a high viscosity formulation, to eliminate such issues as fear of self administration with needles, and needle stick and cross contamination.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 2, 2016
    Applicant: ZOGENIX, INC.
    Inventors: Stephen J. FARR, John TURANIN, Roger HAWLEY, Jeffrey A. SCHUSTER
  • Publication number: 20160129191
    Abstract: A needle free injector system and a method for delivering a formulation using this system are disclosed. The method comprises actuating a needle free injector to pressurize a liquid formulation and force the formulation through an orifice in a skin puncture phase followed by injection of the formulation during a delivery phase. The skin puncture phase is defined by a pressure profile vs. time curve after actuation which has a main pressure peak with a maximum pressure. The delivery phase occurs at a lower pressure than the maximum pressure of the main peak pressure. The device may have one or more orifices and pressurizing the formulation during the puncture phase and delivery phase to extrude the formulation through each orifice is structured so as to improve characteristics of needle free delivery.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 12, 2016
    Applicant: ZOGENIX, INC.
    Inventors: BROOKS M. BOYD, Jeffrey A. SCHUSTER
  • Publication number: 20160129182
    Abstract: A monitoring system comprising a monitor is disclosed that utilizes a vibration sensor to monitor the occurrence and properties of an event. The monitor does not require disassembly of the device to be monitored, or interfere with the operation of the device to be monitored, because the monitor is affixed to the exterior of a device to be monitored or a component thereof, or is integrated into the design of the device to be monitored. In a preferred embodiment, the device to be monitored is a drug delivery device, most preferably an inhaler or autoinjector. The monitoring system includes a display device such as a smartphone or tablet computer for analyzing data related to the device to be monitored usage and displaying information to a user, patient and/or caregiver before, during, and after a usage event. Preferred embodiment monitor the inhalation flow rate through an inhaler, and the dose delivered by an injector.
    Type: Application
    Filed: January 14, 2016
    Publication date: May 12, 2016
    Applicant: OSCILLARI LLC
    Inventors: Jeffrey A. SCHUSTER, Stephen J. FARR, Reuben HALE
  • Publication number: 20160051466
    Abstract: Systems and methods are described for treating un-met medical needs in migraine and related conditions such as cluster headache. Included are treatments that are both rapid onset and long acting, which include sustained release formulations, and combination products. Also included are treatments for multiple symptoms of migraine, especially headache and nausea and vomiting. Systems that are self contained, portable, prefilled, and simple to self administer at the onset of a migraine attack are disclosed, and preferably include a needle-free injector and a high viscosity formulation, to eliminate such issues as fear of self administration with needles, and needle stick and cross contamination.
    Type: Application
    Filed: November 3, 2015
    Publication date: February 25, 2016
    Inventors: Stephen J. FARR, John TURANIN, Roger HAWLEY, Jeffrey A. Schuster
  • Patent number: 9265888
    Abstract: A needle free injector system and a method for delivering a formulation using this system are disclosed. The method comprises actuating a needle free injector to pressurize a liquid formulation and force the formulation through an orifice in a skin puncture phase followed by injection of the formulation during a delivery phase. The skin puncture phase is defined by a pressure profile vs. time curve after actuation which has a main pressure peak with a maximum pressure. The delivery phase occurs at a lower pressure than the maximum pressure of the main peak pressure. The device may have one or more orifices and pressurizing the formulation during the puncture phase and delivery phase to extrude the formulation through each orifice is structured so as to improve characteristics of needle free delivery.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: February 23, 2016
    Assignee: ZOGENIX, INC.
    Inventors: Brooks M. Boyd, Jeffrey A. Schuster